Los Altos, CA, United States of America

Nick Reinig

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Roche Molecular Systems, Inc.. Active years: 2020.


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Nick Reinig

Introduction

Nick Reinig is an accomplished inventor based in Los Altos, California. He has made significant contributions to the field of analytical chemistry, particularly in the detection of analytes. His work has implications for medical diagnostics, especially in identifying pathogens like MRSA.

Latest Patents

Reinig holds a patent for a method titled "Detecting an analyte in a flash and glow reaction." This innovative approach provides accurate measurements of the presence or absence of an analyte in a sample. The method involves subjecting the sample to an activation reagent, which generates a flash signal that can be measured over time. By applying a quadratic regression function to the signal data points, Reinig's technique allows for the determination of accuracy and a signal-to-background ratio. This information can then be used to assess whether the analyte is present in the sample.

Career Highlights

Throughout his career, Nick Reinig has worked with notable companies in the biotechnology sector. He has been associated with Roche Molecular Systems, Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has contributed to his expertise in developing innovative detection methods.

Collaborations

Reinig has collaborated with talented individuals in his field, including Diego Ariel Rey and Paul G. Hayter. These partnerships have likely enhanced his research and development efforts.

Conclusion

Nick Reinig's contributions to the field of analyte detection demonstrate his innovative spirit and commitment to advancing medical diagnostics. His patent reflects a significant step forward in accurately identifying pathogens, which can have a profound impact on public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…